Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma

International Journal of Cancer

Volumn 134, Issue 4, 2014, Pages 844-848

  Faust, Helena ^a   Andersson, Kristin ^a   Ekström, Johanna ^a   Hortlund, Maria ^a   Robsahm, Trude Eid ^b   Dillner, Joakim ^a,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Merkel cell carcinoma; Merkel cell polyomavirus; nonmelanoma skin cancer; prospective case control study; serology; viral infections

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CANCER REGISTRY; CANCER RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; JC VIRUS; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; MIDDLE AGED; NORWAY; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SWEDEN; VERY ELDERLY; VIRION; VIRUS NEUTRALIZATION;

EID: 84890126116     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28419     Document Type: Article

References (31)

1. Albores-Saavedra J, Batich K, Chable-Montero F, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010; 37: 20-7.
2. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100.
3. Foulongne V, Kluger N, Dereure O, et al. Merkel cell polyomavirus in cutaneous swabs. Emerg Infect Dis 2010; 16: 685-7.
4. Schowalter RM, Pastrana DV, Pumphrey KA, et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010; 7: 509-15.
5. Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101: 1510-22.
6. Kean JM, Rao S, Wang M, et al. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009; 5: e1000363.
7. Tolstov YL, Pastrana DV, Feng H, et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009; 125: 1250-6.
8. Touze A, Gaitan J, Arnold F, et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol 2010; 48: 1767-70.
9. Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009; 5: e1000578.
10. Paulson KG, Carter JJ, Johnson LG, et al. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res 2010; 70: 8388-97.
11. Bouvard V, Baan RA, Grosse Y, et al., Group WHOIAfRoCMW. Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol 2012; 13: 339-40.
12. Faust H, Pastrana DV, Buck CB, et al. Antibodies to merkel cell polyomavirus correlate to presence of viral DNA in the skin. J Infect Dis 2011; 203: 1096-100.
13. Pastrana DV, Wieland U, Silling S, et al. Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer. Med Microbiol Immunol 2012; 201: 17-23.
14. Pukkala E, Andersen A, Berglund G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control-more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 2007; 46: 286-307.
15. Sasnauskas K, Buzaite O, Vogel F, et al. Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biol Chem 1999; 380: 381-6.
16. Buck CB, Pastrana DV, Lowy DR, et al. Efficient intracellular assembly of papillomaviral vectors. J Virol 2004; 78: 751-7.
17. Faust H, Knekt P, Forslund O, et al. Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads. J Gen Virol 2010; 91: 1840-8.
18. Grabowska K, Wang X, Jacobsson A, et al. Evaluation of cost-precision rations of different strategies for ELISA measurement of serum antibody levels. J Immunol Methods 2002; 271: 1-15.
19. Arnheim Dahlstrom L, Andersson K, Luostarinen T, et al. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 2541-50.
20. Hazard K, Eliasson L, Dillner J, et al. Subtype HPV38b[FA125] demonstrates heterogeneity of human papillomavirus type 38. Int J Cancer 2006; 119: 1073-7.
21. Lehtinen M, Dillner J, Knekt P, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 1996; 312: 537-9.
22. Langseth H, Luostarinen T, Bray F, et al. Ensuring quality in studies linking cancer registries and biobanks. Acta Oncol 2010; 49: 368-77.
23. Schulz TF,. Cancer and viral infections in immunocompromised individuals. Int J Cancer 2009; 125: 1755-63.
24. Bzhalava D, Bray F, Storm H, et al. Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia. Br J Cancer 2011; 104: 178-80.
25. Kuwamoto S,. Recent advances in the biology of Merkel cell carcinoma. Hum Pathol 2011; 42: 1063-77.
26. Kuwamoto S, Higaki H, Kanai K, et al. Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinoma. Hum Pathol 2011; 42: 632-40.
27. Bhatia K, Goedert JJ, Modali R, et al. Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer 2010; 127: 1493-6.
28. Laude HC, Jonchere B, Maubec E, et al. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog 2010; 6: e1001076.
29. Sihto H, Kukko H, Koljonen V, et al. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009; 101: 938-45.
30. Touze A, Le Bidre E, Laude H, et al. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol 2011; 29: 1612-9.
31. Reichgelt BA, Visser O,. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer 2011; 47: 579-85.